Cargando…
Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) seriously threatens the health of pregnant women and newborns. A various number of Chinese prescriptions and patent medicines combined with ursodeoxycholic acid (UDCA) are used for treating ICP in China. However, there are still many doubts in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670235/ https://www.ncbi.nlm.nih.gov/pubmed/34916949 http://dx.doi.org/10.3389/fphar.2021.774884 |
_version_ | 1784614938561478656 |
---|---|
author | Jiang, Yinxiao Li, Haotian Song, Dan Ye, Penghui Xu, Nuo Chen, Yuan Zhang, Wenwen Hu, Qichao Ma, Xiao Wen, Jianxia Li, Yeyu Zhao, Yanling |
author_facet | Jiang, Yinxiao Li, Haotian Song, Dan Ye, Penghui Xu, Nuo Chen, Yuan Zhang, Wenwen Hu, Qichao Ma, Xiao Wen, Jianxia Li, Yeyu Zhao, Yanling |
author_sort | Jiang, Yinxiao |
collection | PubMed |
description | Background: Intrahepatic cholestasis of pregnancy (ICP) seriously threatens the health of pregnant women and newborns. A various number of Chinese prescriptions and patent medicines combined with ursodeoxycholic acid (UDCA) are used for treating ICP in China. However, there are still many doubts in choosing the suitable therapeutic drugs for the treatment of ICP in clinical practice. Methods: Several electronic databases, including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBM), Wanfang, and VIP, were comprehensively searched from the database inception to February 22, 2021. Randomized controlled trials (RCTs) reporting the use of UDCA only, Chinese prescriptions plus UDCA, and patent medicine plus UDCA for the treatment of ICP were collected according to their inclusion and exclusion criteria. Cochrane Reviewers’ Handbook version 5.2 was applied for the risk assessment of the included trials. STATA 16.0 software was used for network meta-analysis (NMA). The pruritus score and the serum levels of total bile acid (TBA), alanine aminotransferase (ALT), and aspartate transaminase (AST) in ICP patients served as the primary outcomes. Moreover, this study had been registered in PROSPERO (https://www.crd.york.ac.uk/PROSPERO/#joinuppage), and the registration number is CRD42020188831. Results: Thirty-eight RCTs comprising 3,841 patients meeting the inclusion criteria were included in the network meta-analysis. The NMA results showed that compared with UDCA used alone, Yinchenhao decoction (seven different Chinese prescriptions or patent medicines) plus UDCA dramatically alleviated the primary outcomes of ICP, including the pruritus score, as well as the serum levels of TBA, ALT, and AST. The NMA results showed that the optimal drug ratio for the treatment of ICP was different from the dosage ratio of traditional Yinchenhao decoction. Significantly, the intervention plan f (IP-f) group [the similar prescription of Yinchenhao decoction 2 (Artemisia capillaris Thunb >15 g, Gardenia >9 g, and Rhubarb <5 g) + UDCA] was the best therapeutics among the eight therapies. Conclusion: Overall, the combined use of Chinese prescriptions or patent medicine with UDCA was generally better than UDCA used alone. The dose of IP-f might be a beneficial therapeutic method for the clinical medication of ICP. Clinical Trail Registration: https://www.crd.york.ac.uk/, identifier CRD42020188831. |
format | Online Article Text |
id | pubmed-8670235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86702352021-12-15 Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis Jiang, Yinxiao Li, Haotian Song, Dan Ye, Penghui Xu, Nuo Chen, Yuan Zhang, Wenwen Hu, Qichao Ma, Xiao Wen, Jianxia Li, Yeyu Zhao, Yanling Front Pharmacol Pharmacology Background: Intrahepatic cholestasis of pregnancy (ICP) seriously threatens the health of pregnant women and newborns. A various number of Chinese prescriptions and patent medicines combined with ursodeoxycholic acid (UDCA) are used for treating ICP in China. However, there are still many doubts in choosing the suitable therapeutic drugs for the treatment of ICP in clinical practice. Methods: Several electronic databases, including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBM), Wanfang, and VIP, were comprehensively searched from the database inception to February 22, 2021. Randomized controlled trials (RCTs) reporting the use of UDCA only, Chinese prescriptions plus UDCA, and patent medicine plus UDCA for the treatment of ICP were collected according to their inclusion and exclusion criteria. Cochrane Reviewers’ Handbook version 5.2 was applied for the risk assessment of the included trials. STATA 16.0 software was used for network meta-analysis (NMA). The pruritus score and the serum levels of total bile acid (TBA), alanine aminotransferase (ALT), and aspartate transaminase (AST) in ICP patients served as the primary outcomes. Moreover, this study had been registered in PROSPERO (https://www.crd.york.ac.uk/PROSPERO/#joinuppage), and the registration number is CRD42020188831. Results: Thirty-eight RCTs comprising 3,841 patients meeting the inclusion criteria were included in the network meta-analysis. The NMA results showed that compared with UDCA used alone, Yinchenhao decoction (seven different Chinese prescriptions or patent medicines) plus UDCA dramatically alleviated the primary outcomes of ICP, including the pruritus score, as well as the serum levels of TBA, ALT, and AST. The NMA results showed that the optimal drug ratio for the treatment of ICP was different from the dosage ratio of traditional Yinchenhao decoction. Significantly, the intervention plan f (IP-f) group [the similar prescription of Yinchenhao decoction 2 (Artemisia capillaris Thunb >15 g, Gardenia >9 g, and Rhubarb <5 g) + UDCA] was the best therapeutics among the eight therapies. Conclusion: Overall, the combined use of Chinese prescriptions or patent medicine with UDCA was generally better than UDCA used alone. The dose of IP-f might be a beneficial therapeutic method for the clinical medication of ICP. Clinical Trail Registration: https://www.crd.york.ac.uk/, identifier CRD42020188831. Frontiers Media S.A. 2021-11-30 /pmc/articles/PMC8670235/ /pubmed/34916949 http://dx.doi.org/10.3389/fphar.2021.774884 Text en Copyright © 2021 Jiang, Li, Song, Ye, Xu, Chen, Zhang, Hu, Ma, Wen, Li and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Jiang, Yinxiao Li, Haotian Song, Dan Ye, Penghui Xu, Nuo Chen, Yuan Zhang, Wenwen Hu, Qichao Ma, Xiao Wen, Jianxia Li, Yeyu Zhao, Yanling Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis |
title | Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis |
title_full | Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis |
title_fullStr | Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis |
title_full_unstemmed | Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis |
title_short | Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis |
title_sort | comparative evidence for intrahepatic cholestasis of pregnancy treatment with traditional chinese medicine therapy: a network meta-analysis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670235/ https://www.ncbi.nlm.nih.gov/pubmed/34916949 http://dx.doi.org/10.3389/fphar.2021.774884 |
work_keys_str_mv | AT jiangyinxiao comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT lihaotian comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT songdan comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT yepenghui comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT xunuo comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT chenyuan comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT zhangwenwen comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT huqichao comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT maxiao comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT wenjianxia comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT liyeyu comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis AT zhaoyanling comparativeevidenceforintrahepaticcholestasisofpregnancytreatmentwithtraditionalchinesemedicinetherapyanetworkmetaanalysis |